Lipitor, Zocor, Similar Cholesterol Drugs May Increase Risk of Diabetes Progression, Hyperglycemia: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Lipitor, Similar Drugs Should Be Taken By All Diabetics, New Recommendations Say January 2, 2015 Irvin Jackson Add Your Comments New guidelines issued by diabetes experts call for almost all diabetics to begin taking statin-based cholesterol drugs, such as Lipitor and Crestor. The new diabetes control guidelines were issued by the American Diabetes Association (ADA) on December 23, along with a special supplement published in the January issue of Diabetes Care. The new standards indicate that all people diagnosed with diabetes should take either moderate or high dose statins. Roughly 10% of the U.S. population, about 30 million people, have diabetes. If the new standards are followed, tens of millions of more Americans would then be placed on prescription medications like Lipitor, Crestor, Zocor, or a similar drug, which are already among the most widely used drugs in the world. Learn More About Crestor Lawsuits According to lawsuits, side effects of Crestor may increase risk of diabetes. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Crestor Lawsuits According to lawsuits, side effects of Crestor may increase risk of diabetes. Learn More SEE IF YOU QUALIFY FOR COMPENSATION While the new standards take a monolithic, all-inclusive approach to statins, the ADA calls for moderation and individualization in almost every other area. The guidelines raise questions about diabetes therapy focusing on glucose control, and focus on individualized treatment. “Accordingly, instead of a one-size-fits-all approach, personalization is necessary, balancing the benefits of glycemic control with its potential risks, taking into account the adverse effects of glucose-lowering medications (particularly hypoglycemia), and the patient’s age and health status, among other concerns.” The new standards call for diabetics to be active at least every 90 minutes and to perform resistance training twice a week if physically able. Statins and Diabetes The standards come as a response to cardiovascular risk guidelines issued about a year ago by the American College of Cardiology (ACC) and the American Heart Association (AHA). However, those guidelines themselves have come under fire, with critics indicating that they would result in too many Americans being put on statins unnecessarily, exposing them to potential risks associated with the medication, which includes an increased risk of diabetes. In fact, the ADA’s step back from reliance on glucose levels, at the same time that it calls for increased statin use, comes amid increasing concerns that statins actually can lead to blood glucose problems and increase the odds of a person developing diabetes in the first place. A study published in the medical journal The Lancet in September 2014 indicates that the enzyme statins are designed to inhibit in order to control cholesterol is also tied to a number of factors affecting blood sugar. The enzyme is known as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), and the researchers looked at gene variants and how they affected plasma lipid, glucose, and insulin concentrations. The study substituted the gene variants for the effects statins have on HMGCR production. Researchers had data on more than 200,000 individuals from 43 genetic studies. Like the ACC and AHA recommendations last year, the ADA’s new standards argue for doctors not to focus on LDL, or “bad cholesterol” levels, and instead look at the patient’s “risk profile.” “The big change here is to recommend starting either moderate or high-intensity statins based on the patient’s risk profile rather than on LDL level,” said Dr. Richard Grant, chair of the ADA’s Professional Practice Committee, and a research scientist with Kaiser Permanente. “Since all patients with diabetes are at increased risk, it is just a matter of deciding whom to start on moderate versus high-intensity statin doses.” However, another recent study raised questions about the safety of high-potency statins, specifically tying them to increasing diabetes risk. In June, Canadian researchers reported in the British Medical Journal (BMJ) that they had found users of high potency statins, including Lipitor, Crestor, and Zocor, may face a 15% increased risk of being diagnosed with diabetes within two years of starting treatment. The researchers estimated that for every 350 patients given a high potency statin instead of a low potency statin, one of them would contract diabetes. Crestor, Lipitor and Zocor are not only high potency statins, but they are also among the most popular drugs in the class. All other statin-based medications were considered to be lower potency cholesterol drugs. It is unclear how the increased diabetes risk actually impacts patients who already have diabetes, however. Crestor, Lipitor Diabetes Concerns Statins generate combined sales of more than $14.5 billion per year, and are increasingly used to block the body’s creation of cholesterol, which is a key contributor to coronary artery disease. Although the medications are widely used, a number of studies have linked statins to an increased risk of potentially serious injuries, including muscle damage, kidney problems, and diabetes. In February 2012, the FDA required the makers of Lipitor, Crestor and other statins to add new warnings about the potential impact of the medication on blood glucose levels. However, many critics have suggested that the warnings are not strong enough for certain medications, indicating that users and the medical community should be provided with more accurate information about the diabetes risks with Lipitor, Crestor and other statins. Pfizer currently faces hundreds of Lipitor diabetes lawsuits filed by women throughout the United States, who allege that the drug maker knew or should have known about risks associated with their medication for years, but withheld diabetes warnings to avoid a negative impact on sales and growth of the blockbuster medication. AstraZeneca also faces a number of Crestor lawsuits filed on behalf of former users of the cholesterol drug who were diagnosed with diabetes. Most of those cases are currently pending in California state court. Tags: AstraZeneca, Cholesterol, Cholesterol Drugs, Crestor, Diabetes, Diabetes Drugs, Lipitor, Pfizer, Statins, Zocor More Crestor Lawsuit Stories Lipitor, Zocor, Similar Cholesterol Drugs May Increase Risk of Diabetes Progression, Hyperglycemia: Study October 8, 2021 FDA Removing Pregnancy Warning From Cholesterol Drugs Like Lipitor, Zocor July 21, 2021 Lipitor, Zocor, Similar Cholesterol Drugs May Increase Dementia Risks: Study June 22, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (Posted: today) A hairdresser who has worked for nearly 40 years in the industry says her constant exposure to hair dye led to a bladder cancer diagnosis. MORE ABOUT: HAIR DYE LAWSUITSalon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)Hair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025) First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (Posted: today) An Oxbryta class action lawsuit has been scheduled for trial in August 2027, but must first survive a motion to dismiss filed by manufacturers. MORE ABOUT: OXBRYTA LAWSUITMalpractice Lawsuit Alleges Side Effects of Oxbryta Caused Untimely Death (04/15/2025)At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics (03/14/2025)After Recalling Oxbryta, Pfizer Seeks Dismissal of Class Action Brought by Former Users (03/07/2025) Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (Posted: yesterday) Plaintiffs have asked the judge presiding over all AFFF lawsuits to consolidate five claims involving kidney cancer and testicular cancer injuries for the first bellwether trial in the federal MDL. MORE ABOUT: AFFF LAWSUITAdditional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)Firefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)
Lipitor, Zocor, Similar Cholesterol Drugs May Increase Risk of Diabetes Progression, Hyperglycemia: Study October 8, 2021
Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (Posted: today) A hairdresser who has worked for nearly 40 years in the industry says her constant exposure to hair dye led to a bladder cancer diagnosis. MORE ABOUT: HAIR DYE LAWSUITSalon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)Hair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025)
First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (Posted: today) An Oxbryta class action lawsuit has been scheduled for trial in August 2027, but must first survive a motion to dismiss filed by manufacturers. MORE ABOUT: OXBRYTA LAWSUITMalpractice Lawsuit Alleges Side Effects of Oxbryta Caused Untimely Death (04/15/2025)At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics (03/14/2025)After Recalling Oxbryta, Pfizer Seeks Dismissal of Class Action Brought by Former Users (03/07/2025)
Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (Posted: yesterday) Plaintiffs have asked the judge presiding over all AFFF lawsuits to consolidate five claims involving kidney cancer and testicular cancer injuries for the first bellwether trial in the federal MDL. MORE ABOUT: AFFF LAWSUITAdditional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)Firefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)